DE2364470A1 - Farbstabilisierung parenteraler loesungen von cephalosporinen - Google Patents

Farbstabilisierung parenteraler loesungen von cephalosporinen

Info

Publication number
DE2364470A1
DE2364470A1 DE19732364470 DE2364470A DE2364470A1 DE 2364470 A1 DE2364470 A1 DE 2364470A1 DE 19732364470 DE19732364470 DE 19732364470 DE 2364470 A DE2364470 A DE 2364470A DE 2364470 A1 DE2364470 A1 DE 2364470A1
Authority
DE
Germany
Prior art keywords
sodium
cephalosporin
sulfur
potassium
containing compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19732364470
Other languages
German (de)
English (en)
Inventor
Michael Bornstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE2364470A1 publication Critical patent/DE2364470A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
DE19732364470 1972-12-26 1973-12-24 Farbstabilisierung parenteraler loesungen von cephalosporinen Pending DE2364470A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31805472A 1972-12-26 1972-12-26

Publications (1)

Publication Number Publication Date
DE2364470A1 true DE2364470A1 (de) 1974-06-27

Family

ID=23236430

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19732364470 Pending DE2364470A1 (de) 1972-12-26 1973-12-24 Farbstabilisierung parenteraler loesungen von cephalosporinen

Country Status (5)

Country Link
JP (1) JPS4994820A (enrdf_load_stackoverflow)
BE (1) BE809060A (enrdf_load_stackoverflow)
DE (1) DE2364470A1 (enrdf_load_stackoverflow)
FR (1) FR2211215A1 (enrdf_load_stackoverflow)
NL (1) NL7317644A (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115645A (en) * 1977-05-10 1978-09-19 Eli Lilly And Company Decolorizing process for 7-amino-3-(((2-methyl-1,3,4-thiadiazol-5-yl)thio)methyl)-3-cephem-4-carboxylic acid
JPS635091A (ja) * 1986-06-26 1988-01-11 Senjiyu Seiyaku Kk 着色防止方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1272453A (fr) * 1954-08-02 1961-09-29 Merck & Co Inc Procédé de stabilisation de solutions aqueuses de streptomycine

Also Published As

Publication number Publication date
NL7317644A (enrdf_load_stackoverflow) 1974-06-28
FR2211215B1 (enrdf_load_stackoverflow) 1977-09-09
JPS4994820A (enrdf_load_stackoverflow) 1974-09-09
FR2211215A1 (en) 1974-07-19
BE809060A (fr) 1974-06-21

Similar Documents

Publication Publication Date Title
DE69320206T2 (de) Paclitaxel enthaltende injizierbare zusammensetzung
DE69217056T2 (de) Taxan-Derivate enthaltende Arzneimittel
DE69328192T4 (de) Injizierbare Arzneizubereitungen enthaltend Taxanderivate
LU83982A1 (de) Platin-diamin-komplexe,ein verfahren zu ihrer herstellung,ein verfahren zur herstellung eines arzneimittels unter einsatz eines derartigen platin-diamin-komplexes fuer die behandlung von krebs sowie das dabei erhaltene arzneimittel
DE1900367A1 (de) Stabile Glucagonloesung und Verfahren zu ihrer Herstellung
DE2654942C2 (enrdf_load_stackoverflow)
DE1113607B (de) Fungicides Mittel auf der Basis von Manganaethylenbisdithiocarbamat
DE1063378B (de) Verfahren zur Verbesserung der Lichtbestaendigkeit von Gebilden aus Polyamiden
DE2141586C2 (de) Herbizides Saatschutzmittel auf Sulfonatbasis
DE60113255T2 (de) Neue formulierungen von -g(a)-2,4-disulfophenyl-n-tert-butylnitron
DE2364470A1 (de) Farbstabilisierung parenteraler loesungen von cephalosporinen
EP0773281A2 (de) Zubereitungen zur Herstellung wirkstoffstabilisierter Kühlschmiermittelprodukte
EP0074620A2 (de) Verfahren zur Stabilisierung photoinstabiler Arzneistoffe sowie stabilisierte Arzneizubereitungen
DE3040474A1 (de) Karl-fischer-reagenz
DE3522191A1 (de) Photostabilisierung von sydnoniminen
EP0005121B1 (de) Verfahren zum Stabilisieren von 4-Methyl-5-(2'-chloraethyl)-thiazol
DE2052991A1 (de) Stabilisierte wässrige Brenzka techinamin Zubereitung
DE69427595T2 (de) Antitumormittel auf basis von carboplatin und herstellung desselben
DE1053734B (de) Verfahren zur Loeslichmachung und Stabilisierung der Tetracyclinantibiotika
DE1567041A1 (de) Neue Fungizide
EP0143318B1 (de) Verwendung von Formaldehyd oder Paraformaldehyd zur Stabilisierung von Polyethylenthiuramdisulfid
DE2917008C2 (de) Octotiamin enthaltende Präparate
DE1618421B1 (de) Stabilisiertes Manganäthylen-bis-dithiocarbamat und dessen Verwendung
DE1618421C (de) Stabilisiertes Manganäthylen-bisdithiocarbamat und dessen Verwendung
DE3720654C2 (de) Pharmazeutische wäßrige Zusammensetzung und ihre Verwendung als Augen- oder Ohr-Präparat